VA
TNYA icon

VR Adviser’s Tenaya Therapeutics TNYA Stock Holding History

VR Adviser’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,555,556
Closed -$887K – 39
2025
Q1 		$887K Hold
1,555,556
– – 0.08% 35
2024
Q4 		$2.22M Hold
1,555,556
– – 0.15% 34
2024
Q3 		$3M Hold
1,555,556
– – 0.16% 36
2024
Q2 		$4.82M Hold
1,555,556
– – 0.31% 33
2024
Q1 		$8.14M Buy
+1,555,556
New +$7.44M 0.39% 34

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

VR Adviser's TNYA Position: Q2 2025 in Review

VR Adviser sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 1,555,556 shares — an estimated $887K sold.

VR Adviser first reported a position in TNYA in Q1 2024 and held it in 5 quarters. The position peaked at $8.14M in Q1 2024. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • VR Adviser reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • VR Adviser sold 1,555,556 Tenaya Therapeutics shares in Q2 2025, an estimated $887K.
  • VR Adviser first reported a position in Tenaya Therapeutics in Q1 2024 and held it in 5 quarters.
  • VR Adviser's Tenaya Therapeutics position peaked at $8.14M in Q1 2024.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on VR Adviser's 13F filing for Q2 2025, filed 14 Aug 2025.